Pablo Mando (@pablomando) 's Twitter Profile
Pablo Mando

@pablomando

Clinical Oncologist, Breast and Gyn Unit, CEMIC, Buenos Aires, Argentina. YOC member @myESMO @SUMAargentina Board member

ID: 147413791

calendar_today24-05-2010 02:37:24

553 Tweet

694 Takipçi

435 Takip Edilen

Pablo Mando (@pablomando) 's Twitter Profile Photo
Pablo Mando
@pablomando

7 days ago

Inavolisib addition to Palbociclib + Fulvestrant improved OS (34m vs 27m), PFS (17m vs 7m), ORR (62% vs 28%) and DOR (19m vs 11m) in a poor risk population. Impressive delay to first subsequent CT of almost 2y!!! #ASCO2025

Inavolisib addition to Palbociclib + Fulvestrant improved OS (34m vs 27m), PFS (17m vs 7m), ORR (62% vs 28%) and DOR (19m vs 11m) in a poor risk population. Impressive delay to first subsequent CT of almost 2y!!! #ASCO2025